Key result
Concentrations of HuNoV GII RNA in wastewater solids correlate positively with clinical HuNoV positivity rates, supporting the utility of wastewater solids for community infectious disease surveillance.
Why the study?
Actual HuNoV incidence is unknown and surveillance is limited, while prior wastewater monitoring has been mostly restricted to monthly liquid samples at few treatment plants.
Observational
Yes
Wastewater solids monitoring for HuNoV GII RNA correlates with clinical positivity rates, supporting its utility for community infectious disease surveillance.
May augment norovirus surveillance; leaves open prospective validation before routine adoption.
Background Human norovirus (HuNoV) is a leading cause of disease globally, yet actual incidence is unknown. HuNoV infections are not reportable in the United States, and surveillance is limited to tracking severe illnesses or outbreaks. Wastewater monitoring for HuNoV has been done previously and results indicate it is present in wastewater influent and concentrations are associated with HuNoV infections in the communities contributing to wastewater. However, work has mostly been limited to monthly samples of liquid wastewater at one or a few wastewater treatment plants (WWTPs). Objective The objectives of this study are to investigate whether HuNoV GII preferentially adsorbs to wastewater solids, investigate concentrations of HuNoV GII in wastewater solids in wastewater treatment plants across the county, and explore how those relate to clinical measures of disease occurrence. In addition, we aim to develop and apply a mass-balance model that predicts the fraction of individuals shedding HuNoV in their stool based on measured concentrations in wastewater solids. Methods We measured HuNoV GII RNA in matched wastewater solids and liquid influent in 7 samples from a WWTP. We also applied the HuNoV GII assay to measure viral RNA in over 6000 wastewater solids samples from 145 WWTPs from across the United States daily to three times per week for up to five months. Measurements were made using digital droplet RT-PCR. Results HuNoV GII RNA preferentially adsorbs to wastewater solids where it is present at 1000 times the concentration in influent. Concentrations of HuNoV GII RNA correlate positively with clinical HuNoV positivity rates. Model output of the fraction of individuals shedding HuNoV is variable and uncertain, but consistent with indirect estimates of symptomatic HuNoV infections in the United States. Significance These findings support the utility of wastewater solids as a matrix for community infectious disease surveillance. Impact Statement Illness caused by HuNoV is not reportable in the United States so there is limited data on disease occurrence. Wastewater monitoring can provide information about the community spread of HuNoV. Data from wastewater can be available within 24 hours of sample receipt at a laboratory. Wastewater is agnostic to whether individuals seek medical care, are symptomatic, and the severity of illness. Knowledge gleaned from wastewater may be used by public health professionals to make recommendations on hand washing, surface disinfection, or other behaviors to reduce transmission of HuNoV, or medical doctors to inform clinical decision making.
No takes yet. Share an insight, caveat, or question.
Boehm et al. (2023) conducted an observational in Human norovirus (HuNoV) GII. HuNoV GII RNA concentration in wastewater solids was evaluated on Correlation between HuNoV GII RNA concentrations in wastewater solids and clinical HuNoV positivity rates. Concentrations of HuNoV GII RNA in wastewater solids correlate positively with clinical HuNoV positivity rates, supporting the utility of wastewater solids for community infectious disease surveillance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: